Front. Med. Technol. Frontiers in Medical Technology Front. Med. Technol. 2673-3129 Frontiers Media S.A. 10.3389/fmedt.2025.1736962 Correction Correction: Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment AhmedNafees 1 † Data curation Formal analysis Writing – original draft GaurVishwas 2 † Formal analysis Data curation Writing – original draft KamleMadhu 3 Formal analysis Writing – review & editing ChauhanAbhishek 4 Supervision Writing – review & editing ChauhanRitu 5 † Data curation Writing – review & editing KumarPradeep 2 6 * Supervision Writing – review & editing Conceptualization SinghNamita Ashish 1 * Supervision Conceptualization Writing – review & editing Department of Microbiology, Mohanlal Sukhadia University, Udaipur, India Department of Botany, University of Lucknow, Lucknow, India Department of Biochemistry, University of Lucknow, Lucknow, India Amity Institute of Environmental Toxicology Safety and Management, Amity University, Noida, India Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, India College of Life Science & Biotechnology, Korea University, Seoul, Republic of Korea Correspondence: Pradeep Kumar pkbiotech@gmail.com Namita Ashish Singh namita.singh@mlsu.ac.in

These authors have contributed equally to this work

 28112025 2025 71736962 31102025 03112025 © 2025 Ahmed, Gaur, Kamle, Chauhan, Chauhan, Kumar and Singh. 2025Ahmed, Gaur, Kamle, Chauhan, Chauhan, Kumar and Singhhttps://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment By Ahmed N, Gaur V, Kamle M, Chauhan A, Chauhan R, Kumar P and Singh NA (2025). Front. Med. Technol. 7:1695329. doi: 10.3389/fmedt.2025.1695329 gut microbiota dysbiosis metabolic disorder diabetes FMT vaginal microbiota section-at-acceptanceNano-Based Drug Delivery

Author affiliation

Authors affiliations were erroneously assigned. The following affiliations are added:

Amity Institute of Environmental Toxicology Safety and Management, Amity University, Noida, India for author Abhishek Chauhan.

Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India for author Ritun Chauhan.

The following affiliations are being removed:

for author Abhishek Chauhan Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India.

for author Ritu Chauhan Amity Institute of Environmental Toxicology Safety and Management, Amity University, Noida, India.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland